首页> 外文会议>Annual meeting exposition of the Controlled Release Society >Matrix Assisted Solid Oral Dosage Form of Metronidazole for Colon Specific Delivery
【24h】

Matrix Assisted Solid Oral Dosage Form of Metronidazole for Colon Specific Delivery

机译:甲硝唑的基质辅助固体口服剂型用于结肠特异性递送

获取原文

摘要

The aim of the study was to formulate a dosage form for Metronidazole (MTZ) that will specifically deliver the drug into the colon. The approach based on a combination of pH-dependent and time-controlled release mechanism was used. pH-dependent release can be assured by enteric coating and drug release was delayed further for a predetermined time during transit through the small intestine. Effect of use of polymers as both matrices and binders in the tablet formulation was evaluated by in vitro release studies. All the batches of formulations were prepared and evaluated by various parameters -Weight variation, Size, Hardness, Friability, and Determination of Drug Contents.Guar gum,xanthan gum matrix tablets were formulated using different polymers such as Chitosan Eudragit E, Eudragit S-100, as binders, varying the matrix material as well as binder and their concentration affects drug release from the prepared tablets.In the combination of guar gum-xanthan gum matrix tablets, as the amount of xanthan gum was increased into the tablet, the drug release rate decreased but increase in swelling was seen due to the gel forming property of gum. Swelling was more in xanthan gum in as compared to guar gum matrix tablets of MTZ. Swelling increased as the concentration of matrix material i.e. gum was increased. Swelling tendency was more prominent in tablets containing combination of both guar gum and xanthan gum.The susceptibility of matrix tablet containing guar gum/ xanthan gum to the enzymatic activity of colonic bacteria was assessed by conducting the drug release studies in pH 6.8 phosphate buffer containing rat caecal contents because of their similarity with those of humans with respect to intestinal microflora .The presence of rat caecal content in dissolution medium resulted in an appreciable increase in drug release because of the presence of micro organism in the rat caecal content, which caused faster biodeeradation of polymer.
机译:该研究的目的是为甲硝唑(MTZ)配制一种剂型,该剂型将药物特异性地递送到结肠中。使用了基于pH依赖性和时间控制释放机制相结合的方法。可通过肠溶衣确保pH依赖性释放,并且在通过小肠的过程中药物释放会进一步延迟预定时间。通过体外释放研究评估了在片剂中使用聚合物作为基质和粘合剂的效果。制备所有批次的制剂并通过各种参数进行评估-重量变化,大小,硬度,脆性和药物含量测定。瓜耳胶,黄原胶基质片剂使用不同的聚合物如壳聚糖Eudragit E,Eudragit S-100配制作为粘合剂,改变基质材料以及粘合剂及其浓度会影响所制备片剂的药物释放。在瓜尔胶-黄原胶基质片剂的组合中,随着黄原胶量增加到片剂中,药物释放速率降低,但由于树胶的凝胶形成性能而观察到溶胀增加。与MTZ的瓜尔胶基质片剂相比,黄原胶中的溶胀更多。溶胀随着基质材料即树胶的浓度增加而增加。在含有瓜耳胶和黄原胶的组合片剂中,溶胀趋势更为明显。通过在含pH 6.8磷酸盐缓冲液的大鼠中进行药物释放研究,评估了含有瓜耳胶/黄原胶的基质片剂对结肠细菌酶活性的敏感性。盲肠内容物是因为它们与人类肠道菌群的相似性。由于盲肠内容物中存在微生物,溶解介质中大鼠盲肠内容物的存在导致药物释放的明显增加,这导致了更快的生物降解聚合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号